TriAgenics Adds 20th International Patent to its Medical Device Portfolio
U.S. based oral health company further strengthens its global intellectual property position for novel 3rd molar tooth bud ablation (3TBA) technology. TriAgenics, the.
Dentistry Today is The Nation’s Leading Clinical News Magazine for Dentists. Here you can get the latest dental news from the whole world quickly.
U.S. based oral health company further strengthens its global intellectual property position for novel 3rd molar tooth bud ablation (3TBA) technology. TriAgenics, the.
A high-precision, fully guided micro-ablation system has been developed to eliminate the postoperative problems normally associated with third molar formation. Third molar removal is.
TriAgenics’ fully guided tooth bud ablation treatment (3TBA) is designed to eliminate problems associated with current third molar management strategies. Managing complications associated.
The Clinical Rationale Behind Fully Guided Third Molar Tooth Bud Ablation Clinical management of third molars has remained largely unchanged for the past.
Imagine a one-minute, surgery-free treatment that stops wisdom teeth from ever forming. New research published in The Journal of Oral and Maxillofacial Surgery shows.